HOME >> BIOLOGY >> NEWS
Transcription factor protein's role in cell death, neurodegeneration and schizophrenia

PHILADELPHIA -- Researchers at the University of Pennsylvania School of Medicine discovered that a protein called Elk-1 interacts with mitochondria, the energy storehouse of a cell, suggesting that this protein - typically active in the nucleus -- could play a role in cell death and mitochondria-related diseases such as neurodegeneration and schizophrenia.

The neuron is a particular type of cell in the brain that is responsible for, among other tasks, learning and memory, cognitive function, and other higher order physiologies. The neuronal cell exhibits a complex structure where fine hair-like structures called dendrites receive signals from other neurons. These signals are transferred to the soma, or body, of the cell and result in neuronal responsiveness to stimulation.

The researchers found that mRNA (messenger RNA) and protein encoding Elk-1, a transcription factor, were localized in the dendrites of intact rodent neurons. "Transcription factors normally only function in the nucleus and to find a transcription factor in the dendrite is pretty unique," says senior author James Eberwine, Ph.D., professor of pharmacology. "These factors are proteins that bind to DNA and play a role in the regulation of gene expression by promoting transcription. Our lab and others showed that Elk-1 is present in the dendrites of nerve cells." Transcription is the process of translating the DNA code into protein.

Along with Eberwine, co-authors Lindy Barrett, Ph.D., a student from the Eberwine lab who was recently awarded her doctorate in philosophy; Philip Haydon, Ph.D., professor of neuroscience; Jai Yoon Sul, Ph.D., a postdoctoral fellow in the Haydon lab; and colleagues published their findings in the June issue of Nature Methods and a March issue of the Proceedings of the National Academy of Sciences.

In the series of experiments (described in the PNAS study) to discern the nature of Elk-1's role in the dendrite, the investigators first charac
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
7-Jun-2006


Page: 1 2 3

Related biology news :

1. Location, location, location: Transcriptional activity and nuclear position
2. Eye candy: Transcriptional control of vertebrate eye development
3. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
4. OHSU turns mouse into factory for human liver cells
5. Genetic factors strongly shape how peers are chosen
6. Injection drug use the most important risk factor for HIV and HCV infections among Quebec prisoners
7. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
8. New model for autism suggests women carry the disorder and explains age as a risk factor
9. Obesity found to be a risk factor for multiple myeloma
10. Journal of Alzheimers Disease achieves significant impact factor
11. Tomorrows green nanofactories

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... Modality Solutions, a biopharmaceutical cold ... Inc. 5000 list. The list is the most prestigious ranking of the nation’s fastest-growing ... for this year’s list, reported three-year revenue growth of 71 percent. , The ...
(Date:8/21/2020)... ... 2020 , ... “How can we help?”, asks Hans Schroeder, ... for more than twenty years. Together with Douglas Granger, Ph.D., founder of Salimetrics ... of Interdisciplinary Saliva Research and Applications ," and Steven Granger, Ph.D., Chief Scientific ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, ... have entered into license agreements with Housey Pharma’s HMI subsidiary to gain access ... J&J have annual Research and Development spending in excess of US $10 billion. ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
(Date:7/10/2020)... LORTON, Va. (PRWEB) , ... July 08, 2020 ... ... laboratory testing services and products, announces a significant expansion of laboratory operations through ... robust collection for agencies implementing testing programs. , Bode-CARES provides ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., ... and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson ...
(Date:7/1/2020)... CHARLOTTE, N.C. (PRWEB) , ... June 29, 2020 ... ... has reported year to date growth of 40% in 2020, despite many obstacles ... medical technology, MedShift aims to increase revenue for its partnered medical practices and ...
Breaking Biology Technology:
Cached News: